Abstract
Objective of this research is to explore the complex correlations among FT3, FT4 and TSH in thyroid dysfunction states. A total of 3425 outpatients were included to analyze their thyroid function tests measured at the university teaching hospital. The subjects under study were categorized as euthyroid (70.45%), subclinical hypothyroid (18.95%), overt hypothyroid (3.30%), subclinical hyperthyroid (5.11%) and overt hyperthyroid (2.19%) patients. The linear and non-linear relations among FT3, FT4 and TSH were modeled statistically to understand their role in thyroid functions. The prevalence of hypothyroidism is higher than hyperthyroidism in which females are more vulnerable than males. The correlation between FT3 and FT4 increases from euthyroidism (r = 0.1, P < 0.001) to overt thyroid dysfunctions (r = 0.91, P < 0.001). The non-linear complex correlations between FT4 and TSH are significantly explained by well fitted sigmoid curves of four-parameter logistic (4PL) model (R2 = 0.97 and P < 0.001) in both hypothyroidism and hyperthyroidism interfaced with euthyroidism. The 4PL curves are response trajectories of pituitary TSH which exhibit the turning points of thyroid dysfunction states by the deviation in serum FT4. The negative slopes and correlations observed in the linear fits in TSH vs FT3 or FT4 are the indicators of negative feedback mechanism in the thyroid cycle.
Similar content being viewed by others
REFERENCES
R. Hoermann, J. E. Midgley, A. Giacobino, et al., Clin. Endocrinol. 81, 907 (2014).
N. C. Hadlow, K. M. Rothacker, R. Wardrop, et al., J. Clin. Endocrinol. Metab. 98, 2936 (2013).
G. Kozdag, D. Ural, A. Vural, et al., Eur. J. Heart Fail. 7, 113 (2005).
B. Biondi, and D. S. Cooper, Endocr. Rev. 29, 76 (2007).
T. R. Lamichhane, S. P. Pant, B. Lamichhane, et al., J. Biosci. Med. 6, 59 (2018).
E. N. Pearce, A. P. Farwell, and L. E. Braverman, N. Engl. J. Med. 348, 2646 (2003).
C. T. Sawin, D. Chopra, F. Azizi, et al., J. Am. Med. Assoc. 242, 247 (1979).
P. R. Larsen, J. E. Silva, and M. M. Kaplan, Endocr. Rev. 2, 87 (1981).
N. Benhadi, E. Fliers, T. J. Visser, et al., Eur. J. Endocrinol. 162, 323 (2010).
R. Hoermann, W. Eckl, C. Hoermann, et al., Eur. J. Endocrinol. 162, 1123 (2010).
M. K. S. Leow, J. Theor. Biol. 248, 275 (2007).
P. M. Clark, R. L. Holder, S. M. Haque, et al., J. Clin. Pathol. 65, 463 (2012).
S. Reichlin, and R. D. Utiger, J. Clin. Endocrinol. Metab. 27, 251 (1967).
J. E. Midgley, R. Hoermann, R. Larisch, et al., J. Clinl. Pathol. 66, 335 (2013).
E. Bortolotto, R. Rousseau, B. Teodorescu, et al., Bioprocess Int. 13, 26 (2015).
M. Azadeh, B. Gorovits, J. Kamerud, et al., AAPS J. 20, 22 (2018).
N. Manji, J. D. Carr-Smith, K. Boelaert, et al., J. Clin. Endocrinol. Metab. 91, 4873 (2006).
J. V. Fade, J. A. Franklyn, K. W. Cross, et al., Clin. Endocrinol. 34, 77 (1991).
Y. Aoki, R. M. Belin, R. Clickner, et al., Thyroid 17, 1211 (2007).
G. J. Canaris, N. R. Manowitz, G. Mayor, et al., Arch. Intern. Med. 160, 526 (2000).
L. M. Prisant, J. S. Gujral, and A. L. Mulloy, J. Clin. Hypertens. 8, 596 (2006).
S. Mariotti, C. Franceschi, A. Cossarizza, et al., Endocr. Rev. 16, 686 (1995).
M. P. J. Van Boxtel, P. P. C. A. Menheere, O. Bekers, et al., Psychoneuroendocrinology 29, 891 (2004).
S. Rabbiosi, M. C. Vigone, F. Cortinovis, et al., J. Clin. Endocrinol. Metab. 98, 1395 (2013).
V. Bacci, G. C. Schussler, and T. B. Kaplan, J. Clin. Endocrinol. Metab. 54, 1229 (1982).
A. Engum, T. Bjøro, A. Mykletun, et al., Acta Psychiatr. Scand. 106, 27 (2002).
R. Bunevicius, and A. J. Prange, Jr., Curr. Opin. Psychiatr. 23, 363 (2010).
J. Jonklaas, N. Kahric-Janicic, O. P. Soldin, at al., Clin. Chem. 55, 1380 (2009).
M. K. S. Leow, Front. Endocrinol. 7, 64 (2016).
J. Berberich, J. W. Dietrich, R. Hoermann, at al., Front. Endocrinol. 9, 91 (2018).
Funding
This work was partially supported by Nepal Academy of Science and Technology (NAST) through a grant of PhD fellowship to the first author.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
Conflict of interest. The authors declare that they have no conflicts of interest.
Statement of compliance with standards of research involving humans as subjects. This research work has been performed under the ethical guidelines provided by and taking authority from Institutional Review Board (IRB), Institute of Medicine (IOM), Tribhuvan University Teaching Hospital (TUTH), Maharajgunj, Kathmandu, Nepal.
DATA AVAILABILITY
The data used to support the findings of this study are available from the corresponding author upon request.
Additional information
Abbreviations: FT3, serum free triiodothyronine; FT4, serum free teraiodothyronine; TSH, thyroid stimulating hormone or thyrotropin; TFT, thyroid function test; 4PL, four parameter logistic.
Rights and permissions
About this article
Cite this article
Lamichhane, T.R., Pant, S.P., Lamichhane, B. et al. Evaluation of Thyroid Hormones-Thyrotropin Interrelationships in Thyroid Dysfunction States from Population-Based Data Analysis with a Logistic Model. BIOPHYSICS 67, 281–287 (2022). https://doi.org/10.1134/S0006350922020130
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350922020130